← FDA Drug Approvals (Drugs@FDA)

TEVETEN HCT

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2001-11-01

Drug application

FDA Application #

NDA021268

Application type

New Drug Application

Brand name

TEVETEN HCT

Generic name

Eprosartan Mesylate

Active ingredients

EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

2001-11-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown